These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects. Shen Z, Gillen M, Miner JN, Bucci G, Wilson DM, Hall JW. Drug Des Devel Ther; 2017 Oct; 11():2077-2086. PubMed ID: 28744099 [Abstract] [Full Text] [Related]
10. Renal handling of urate in healthy man in hyperuricaemia and renal insufficiency: circadian fluctuation, effect of water diuresis and of uricosuric agents. Lang F, Greger R, Oberleithner H, Griss E, Lang K, Pastner D, Dittrich P, Deetjen P. Eur J Clin Invest; 1980 Aug; 10(4):285-92. PubMed ID: 6775956 [Abstract] [Full Text] [Related]
12. A new uricosuric substance 5-[(1H-imidazol-1-yl)phenylmethyl]-2-methyl-1H-benzimidazole (C18H16N4). Gresser U, Zöllner N. Klin Wochenschr; 1989 Jun 15; 67(12):645. PubMed ID: 2770180 [No Abstract] [Full Text] [Related]
19. Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice. Yamada H, Kotaki H, Furitsu H, Sawada Y, Iga T. Biopharm Drug Dispos; 1999 Jul 15; 20(5):271-6. PubMed ID: 10594872 [Abstract] [Full Text] [Related]